Category: Health

Categories
Health

U.S. Is Blind to Contagious New Virus Variant, Scientists Warn

U.S. Is Blind to Contagious New Virus Variant, Scientists Warn

Experten warnen davor, dass die Vereinigten Staaten ohne ein robustes System zur Identifizierung genetischer Variationen des Coronavirus schlecht gerüstet sind, um eine gefährliche neue Mutante aufzuspüren, und lassen die Gesundheitsbeamten blind, wenn sie versuchen, die schwerwiegende Bedrohung zu bekämpfen.

Die Variante, die jetzt in Großbritannien auf dem Vormarsch ist und die Krankenhäuser mit neuen Fällen belastet, ist in den USA derzeit selten. Aber es könnte in den nächsten Wochen explodieren und neuen Druck auf amerikanische Krankenhäuser ausüben, von denen einige bereits kurz vor dem Bruch stehen.

In den Vereinigten Staaten gibt es kein landesweites System zur Überprüfung des Coronavirus-Genoms auf neue Mutationen, einschließlich derjenigen, die von der neuen Variante getragen werden. Ungefähr 1,4 Millionen Menschen testen jede Woche positiv auf das Virus, aber Forscher führen nur eine Genomsequenzierung durch – eine Methode, mit der die neue Variante definitiv erkannt werden kann – an weniger als 3.000 dieser wöchentlichen Proben. Und diese Arbeit wird von einem Flickenteppich aus akademischen, staatlichen und kommerziellen Labors geleistet.

Wissenschaftler sagen, dass ein nationales Überwachungsprogramm in der Lage sein würde, festzustellen, wie weit verbreitet die neue Variante ist, und dabei zu helfen, aufkommende Krisenherde einzudämmen, was das entscheidende Zeitfenster verlängert, in dem schutzbedürftige Menschen im ganzen Land geimpft werden könnten. Das würde mehrere hundert Millionen Dollar oder mehr kosten. Während dies wie ein steiler Preis erscheinen mag, ist es ein winziger Bruchteil der 16 Billionen US-Dollar an wirtschaftlichen Verlusten, die die Vereinigten Staaten aufgrund von Covid-19 schätzungsweise erlitten haben.

“Wir brauchen eine Art Führung”, sagte Dr. Charles Chiu, ein Forscher an der University of California in San Francisco, dessen Team einige der ersten Fälle der neuen Variante in Kalifornien entdeckte. „Dies muss ein System sein, das auf nationaler Ebene implementiert wird. Ohne diese engagierte Unterstützung geht es einfach nicht. “

Mit einem solchen System könnten Gesundheitsbeamte die Öffentlichkeit in den betroffenen Gebieten warnen und neue Maßnahmen einleiten, um mit der Variante fertig zu werden – beispielsweise die Verwendung besserer Masken, Kontaktverfolgung, Schließung von Schulen oder vorübergehende Sperrungen – und dies frühzeitig tun, anstatt zu warten Eine neue Welle überflutete Krankenhäuser mit Kranken.

Die eingehende Biden-Administration ist möglicherweise offen für die Idee. “Der gewählte Präsident unterstützt ein nationales Testprogramm, das dazu beitragen kann, die Verbreitung von COVID-19 zu stoppen und Varianten zu finden”, sagte TJ Ducklo, ein Sprecher des Übergangs. „Das bedeutet mehr Tests, mehr Laborkapazität und Genomsequenzierung. Dies ist wichtig, um COVID-19 zu kontrollieren und die USA darauf vorzubereiten, zukünftige Krankheitsbedrohungen zu erkennen und zu stoppen. “

Experten verweisen auf Großbritannien als Vorbild dafür, was die USA tun könnten. Britische Forscher sequenzieren das Genom – das heißt das gesamte genetische Material in einem Coronavirus – aus bis zu 10 Prozent der neuen positiven Proben. Selbst wenn die USA nur ein Prozent der Genome aus dem ganzen Land oder etwa 2.000 neue Proben pro Tag sequenzieren würden, würde dies ein helles Licht auf die neue Variante sowie andere möglicherweise auftretende Varianten werfen.

Aber die USA verfehlen dieses Ziel jetzt weit. Im vergangenen Monat haben amerikanische Forscher laut GISAID, einer internationalen Datenbank, in der Forscher neue Genome von Coronaviren teilen, nur einige hundert Genome pro Tag sequenziert. Und nur wenige Staaten waren für den größten Teil der Bemühungen verantwortlich. Kalifornien liegt mit 8.896 Genomen an der Spitze. In North Dakota, wo bisher mehr als 93.500 Fälle aufgetreten sind, haben Forscher kein einziges Genom sequenziert.

Im März startete Großbritannien das, wonach sich viele amerikanische Experten sehnen: ein gut geführtes nationales Programm zur Verfolgung von Mutationen des neuen Coronavirus. Das Land investierte 20 Millionen Pfund – ungefähr 27 Millionen US-Dollar – in die Schaffung eines wissenschaftlichen Konsortiums, das Krankenhäuser im ganzen Land einbezog und ihnen Standardverfahren für den Versand von Proben an spezielle Labors gab, in denen ihre Viren sequenziert wurden. Mithilfe von Cloud Computing analysierten Experten die Mutationen und fanden heraus, wo jede Linie des Virus auf einen Evolutionsbaum passt.

“Was Großbritannien mit der Sequenzierung getan hat, ist für mich der Mondschuss der Pandemie”, sagte Emma Hodcroft, eine molekulare Epidemiologin an der Universität Bern in der Schweiz, die Nextstrain, ein in Seattle ansässiges Projekt zur Verfolgung von Krankheitserregern, mitgestaltet hat. “Sie haben beschlossen, Sequenzierung zu machen, und sie haben einfach ein absolut unglaubliches Programm von Grund auf neu erstellt.”

Das intensive Programm Großbritanniens zur Verfolgung der genetischen Entwicklung des Coronavirus ist wahrscheinlich der Grund, warum es im vergangenen Monat als erstes Land die neue Variante namens B.1.1.7 identifiziert hat. Großbritannien hat bisher 209.038 Coronavirus-Genome sequenziert – fast zwei Drittel aller weltweit sequenzierten. Die USA, ein fünfmal größeres Land, haben nur 58.560 Genome sequenziert.

In den USA hat eine Konstellation von Labors, hauptsächlich an Universitäten, seit dem Frühjahr Coronavirus-Genome analysiert. Viele von ihnen geben ihre eigenen bescheidenen Mittel aus, um die Arbeit zu erledigen. “Es kommt alles auf diese Basisbewegungen an, um es in Gang zu bringen”, sagte Kristian Andersen, Virologe am Scripps Research Institute in San Diego, dessen Labor an der Spitze dieser Bemühungen steht.

Aktualisiert

6. Januar 2021, 19:09 Uhr ET

Dr. Andersen und andere Wissenschaftler beleuchteten den Weg des Coronavirus, der sich über den Globus und die Vereinigten Staaten ausbreitete. Einige der frühen Fälle in den Vereinigten Staaten stammten aus China, dem Geburtsort des neuartigen Coronavirus, aber es waren Reisende aus Europa, die die meisten Fälle in viele amerikanische Städte brachten.

Nach diesen ersten Erfolgen wurde das Screening jedoch nur in geringem Umfang fortgesetzt. “Es hat sicherlich nicht zu einer Revolution in der genomischen Überwachung geführt”, sagte Dr. Andersen.

Im Mai haben die Zentren für die Kontrolle und Prävention von Krankheiten Dutzende von Labors in den USA in einem Konsortium zusammengeführt. Es ist bekannt als SARS-CoV-2-Sequenzierung für das Notfallkonsortium für öffentliche Gesundheit, Epidemiologie und Überwachung oder SPHÄREN.

Wissenschaftler, die an SPHERES teilnehmen, sagen, dass dies ein guter Anfang war. “Es ist ein wirklich nützliches Netzwerk für Wissenschaftler, Akademiker und Forscher, um sich in den USA gegenseitig zu helfen”, sagte Dr. Hodcroft. Labore, die sich an der Sequenzierung von Coronavirus-Genomen beteiligen wollten, konnten sich von anderen Labors beraten lassen, anstatt das wissenschaftliche Rad neu zu erfinden.

Es handelt sich jedoch nicht um ein nationales Programm mit einem klaren Mandat und Ressourcen, um sicherzustellen, dass Mutationen in den USA sorgfältig überwacht werden. “Als Land brauchen wir eine genomische Überwachung”, sagte Dr. Andersen. “Es braucht ein Bundesmandat.”

Die CDC lehnte es ab, die Wissenschaftler, die SPHERES betreiben, für ein Interview zur Verfügung zu stellen. “CDC arbeitet mit staatlichen Laboratorien für öffentliche Gesundheit, Wissenschaft und Handel zusammen, um die Kapazität zur Überwachung häuslicher Stämme zu erhöhen und wöchentlich Tausende von Proben zu sequenzieren”, schrieb Brian Katzowitz, ein Sprecher der Agentur, in einer Erklärung.

Der Coronavirus-Ausbruch >

Wissenswertes zum Testen

Verwirrt von den Bedingungen zum Testen von Coronaviren? Lasst uns helfen:

    • Antikörper: Ein vom Immunsystem produziertes Protein, das bestimmte Arten von Viren, Bakterien oder anderen Eindringlingen erkennen und genau daran binden kann.
    • Antikörpertest / Serologietest: Ein Test, der für das Coronavirus spezifische Antikörper nachweist. Ungefähr eine Woche, nachdem das Coronavirus den Körper infiziert hat, beginnen Antikörper im Blut zu erscheinen. Da die Entwicklung von Antikörpern so lange dauert, kann ein Antikörpertest eine laufende Infektion nicht zuverlässig diagnostizieren. Es kann jedoch Personen identifizieren, die in der Vergangenheit dem Coronavirus ausgesetzt waren.
    • Antigen-Test: Dieser Test erkennt Teile von Coronavirus-Proteinen, die als Antigene bezeichnet werden. Antigen-Tests sind schnell und dauern nur fünf Minuten. Sie sind jedoch weniger genau als Tests, bei denen genetisches Material aus dem Virus nachgewiesen wird.
    • Coronavirus: Jedes Virus, das zur Familie der Orthocoronavirinae-Viren gehört. Das Coronavirus, das Covid-19 verursacht, ist als SARS-CoV-2 bekannt.
    • Covid19: Die durch das neue Coronavirus verursachte Krankheit. Der Name steht für Coronavirus Disease 2019.
    • Isolierung und Quarantäne: Isolation ist die Trennung von Menschen, die wissen, dass sie an einer ansteckenden Krankheit leiden, von denen, die nicht krank sind. Quarantäne bezieht sich auf die Einschränkung der Bewegung von Personen, die einem Virus ausgesetzt waren.
    • Nasopharyngealabstrich: Ein langer, flexibler Stab mit einem weichen Tupfer, der tief in die Nase eingeführt wird, um Proben aus dem Raum zu entnehmen, in dem die Nasenhöhle auf den Hals trifft. Proben für Coronavirus-Tests können auch mit Tupfern entnommen werden, die nicht so tief in die Nase reichen – manchmal auch als Nasentupfer bezeichnet – oder mit Mund- oder Rachenabstrichen.
    • Polymerasekettenreaktion (PCR): Wissenschaftler verwenden PCR, um Millionen Kopien von genetischem Material in einer Probe zu erstellen. Mithilfe von PCR-Tests können Forscher das Coronavirus auch dann nachweisen, wenn es knapp ist.
    • Viruslast: Die Menge an Viren im Körper einer Person. Bei Menschen, die mit dem Coronavirus infiziert sind, kann die Viruslast ihren Höhepunkt erreichen, bevor sie Symptome zeigen, wenn überhaupt Symptome auftreten.

Am Mittwoch kündigten die Gensequenzierungsunternehmen Helix und Illumina eine Zusammenarbeit an, um die Entstehung von B.1.1.7 mit Unterstützung der CDC zu verfolgen. Die Unternehmen sequenzieren bis zu 1.000 Genome pro Woche. Karen Birmingham, eine Sprecherin von Illumina, wies jedoch schnell darauf hin, dass das Pilotprogramm weit entfernt von einer nationalen Anstrengung sei. “Wir begrüßen die genomische Überwachung in den USA viel umfassender und koordinierter”, sagte sie.

Dank des robusten britischen Systems zur genetischen Überwachung konnten Wissenschaftler besser verstehen, wie gefährlich die neue Variante ist. Eine ernüchternde Studie, die am Montag von Forschern des britischen Sequenzierungskonsortiums veröffentlicht wurde, ergab, dass die Sperrung des Landes im November die Übertragung gewöhnlicher Varianten des Coronavirus gut beschleunigte, die Verbreitung von B.1.1.7 jedoch nicht aufhielt.

Epidemiologen messen die Ausbreitungsrate eines Virus mit der sogenannten Reproduktionszahl. Wenn die Fortpflanzungszahl 1 ist, bedeutet dies, dass jede infizierte Person sie im Durchschnitt an eine andere Person weitergibt. Eine wachsende Epidemie hat eine Fortpflanzungszahl von mehr als 1, während eine schwindende Zahl weniger als 1 beträgt. Die britischen Forscher schätzten, dass andere Coronaviren als B.1.1.7 während der Sperrung eine Fortpflanzungszahl von 0,95 hatten, während B.1.1.7 dies getan hatte eine Reproduktionszahl von 1,45.

Die Geschwindigkeit, mit der B.1.1.7 häufiger geworden ist, deutet darauf hin, dass es einige biologische Merkmale aufweist, die eine bessere Ausbreitung von einem Wirt zum anderen ermöglichen. Laborexperimente haben gezeigt, dass einige seiner Mutationen es dem Virus ermöglichen können, sich erfolgreicher an Zellen in den Atemwegen zu binden.

Am Montag gab die britische Regierung bekannt, dass das Land in eine noch strengere nationale Sperrung geraten werde als im November. “Sie dürfen nicht gehen oder außerhalb Ihres Hauses sein, außer wenn dies erforderlich ist”, sagte die Regierung in einem Gutachten.

Es ist noch zu früh, um zu wissen, wie sich B.1.1.7 auf die amerikanische Pandemie auswirken wird – und vor allem, ob es die US-Krankenhäuser wie die in Großbritannien überwältigen wird. Die meisten Menschen, die sich infizieren, geben das Virus nicht an andere weiter. Ein kleiner Teil der Menschen ist für einen Großteil seiner Übertragung in sogenannten Super-Spreading-Ereignissen verantwortlich. Sie landen zur richtigen Zeit am richtigen Ort, um viele Menschen gleichzeitig zu infizieren.

Wenn die neue Variante jedoch dieselbe Flugbahn wie in Großbritannien einschlägt, wird sie in den kommenden Wochen die gängigeren, weniger ansteckenden Varianten übertreffen. “Es könnte in den nächsten Monaten das dominierende Virus werden”, sagte Nathan Grubaugh, Virologe an der Yale University.

Eines ist jedoch sicher. Mitarbeiter des öffentlichen Gesundheitswesens können die Variante nur stoppen, wenn sie sie sehen können. Dr. Grubaugh und andere Wissenschaftler erstellen benutzerdefinierte Tests für B.1.1.7. die PCR verwenden, eine schnelle und kostengünstige Technologie, mit der auf jede Variante des Coronavirus getestet werden kann.

Dr. Grubaugh sagte jedoch, dass es weitaus besser wäre, wenn die Forscher nicht lange nach der Ankunft einer gefährlichen neuen Variante in den USA um diese Tests kämpfen müssten. “Es ist insgesamt nur ein Pflaster für unseren Mangel an genomischer Überwachung”, sagte er.

Ein landesweites Überwachungsprogramm Die Entwicklung des Coronavirus zu verfolgen, würde es Forschern nicht nur ermöglichen, die Ausbreitung von B.1.1.7. zu beobachten, sondern auch andere, möglicherweise noch gefährlichere neue Mutationen, die in seiner Linie auftreten. Neue Varianten könnten menschliche Zellen noch effizienter infizieren oder, schlimmer noch, Impfstoffen oder antiviralen Medikamenten ausweichen.

“Nur weil wir es nicht eingerichtet haben, heißt das nicht, dass wir es nicht tun können”, sagte Dr. Hodcroft. “Wir müssen nur wirklich entscheiden, dass dies etwas ist, was wir wollen.”

Sie betonte, dass der einzige Weg, diese gefährlichen neuen Fehler zu finden, darin bestehe, ständig nach ihnen zu suchen. “Sie tauchen nicht am ersten Tag auf und stellen sich vor und sagen: ‘Hey, schau mir zu!'”, Sagte sie. „Wir brauchen eine Weile, um das herauszufinden. Und wir brauchen länger, wenn wir nicht suchen. “

Categories
Health

California governor cancels Covid briefing over security considerations

California governor cancels Covid briefing over safety concerns

Gavin Newsom, California Governor, speaks during a press conference in Sacramento, California

Rich Pedroncelli | Bloomberg | Getty Images

California Governor Gavin Newsom canceled his planned coronavirus update on Wednesday out of “caution” after a crowd of protesters who supported President Donald Trump stormed the US Capitol.

“We are concerned for the safety of the California Congress delegation and US Capitol staff and we endeavor to provide assistance in any way we can,” the Democratic governor said in a statement, adding that he was concerned about the safety of his own office staff California too.

“Peaceful protest is an important mechanism of our democracy, but what we are seeing in our nation’s Capitol is reprehensible and an outright attack on our democracy and democratic institutions,” Newsom said.

The news comes as California faces the deadliest days of the Covid-19 pandemic. According to a CNBC analysis of data compiled by Johns Hopkins University, the state reports around 354 Covid deaths daily, a record average per week and an increase of nearly 49% compared to a week ago.

A governor’s spokesman told CNBC that the capital’s staff had been asked to work from home for the rest of the day. People who gathered to protest on the Capitol grounds have since left and there have been no major incidents, the spokesman said.

The Sacramento Police Department said in a tweet that 11 people were arrested for illegally possessing pepper spray and that there were some physical fights. However, the protesters have broken up and a large police presence will remain in the area all night.

Categories
Health

Research Says Blood Plasma Reduces Threat of Extreme Covid-19 if Given Early

Study Says Blood Plasma Reduces Risk of Severe Covid-19 if Given Early

It will be difficult “to find and diagnose them in this vanishingly small window,” said Dr. Ilan Schwartz, an infectious disease doctor at the University of Alberta who was not involved in the study. “The study looks solid, but it isn’t exactly practical in the real world.”

Plasma has additional logistical hurdles, said Dr. Titanji from Emory University. Treatment is given as an intravenous infusion – a process that requires skilled hands – and patients must be monitored afterward. That might be easier in long-term care facilities, but far more difficult for the general population, she said.

And plasma may not work as well as monoclonal antibody therapy – a synthetic preparation that is made en masse in the laboratory and not drawn from human blood, and that focuses on only one or two types of antibody at a time, rather than the total amount produced naturally by the immune system. Two types of monoclonal antibody treatments have been approved for emergencies in Covid patients.

But plasma has some advantages over monoclonal antibody treatments, emphasized Dr. Polack.

Because monoclonal antibodies are synthetic and tedious to make, they come at a high price, sometimes costing thousands of dollars (although the US government has prepaid some doses). The limited supply chain of treatment, as well as unexpectedly low demand, have made it inaccessible to many patients in need in the US and abroad.

In countries like Argentina, plasma could be one of the best treatment options available, said Dr. Polack. Plasma infusions in Buenos Aires cost less than $ 200 per patient. “It’s more accessible, cheaper, more universal,” he said.

Even in the United States, plasma “really is the only game in town that is widely available in terms of antibody therapy,” said Dr. Wang from Stanford.

Instead of viewing monoclonal antibodies as an upgrade for convalescent plasma, “they each have a different place in the armory,” said Dr. Pirofski. “Anything this virus can control is really an incredible benefit at this point.”

Categories
Health

What folks may not be allowed to do if they do not get vaccinated

What people might not be allowed to do if they don't get vaccinated

Protester holds an anti-vaccine placard in east London on December 5, 2020.

JUSTIN TALLIS | AFP | Getty Images

LONDON – A perfect storm is brewing as Covid-19 vaccines become increasingly popular in countries around the world.

While many people can’t wait to protect themselves from the virus, some firmly believe they won’t get the sting, so populations will be divided into vaccinated and unvaccinated populations.

One in five people in the UK say they are unlikely to take the vaccine. This is the result of a YouGov study published in November, which gives various reasons.

Due to the different views, a debate could start in 2021. Should restrictions be placed on people who do not wish to be vaccinated as they can catch and spread the virus?

It’s a touchy subject, but governments are already looking into putting in place systems that will allow authorities and possibly businesses to determine whether or not a person has received a Covid vaccine.

China has launched a health code app that shows whether a person is symptom-free to check into a hotel or use the subway. In Chile, citizens who have recovered from the coronavirus have been issued “virus-free” certificates.

On December 28, Spanish Health Minister Salvador Illa said the country would create a register to show who refused to be vaccinated and that the database could be shared across Europe.

Ethical Implications

Isra Black, professor of law at the University of York, and Lisa Forsberg, a postdoctoral fellow at the University of Oxford who studies medical ethics, told CNBC that it is “not easy to say whether this is ethical for a state . ” Impose restrictions “on people who refuse a push.

The scientists said in a joint statement via email that the answer will depend on factors such as vaccine supply, vaccination levels in the population, the nature of restrictions on vaccine objectors, and the implementation of the restrictions.

“We might think that there are strong, if not necessarily decisive, reasons for restricting the regaining of freedoms before the pandemic for people who refuse to be vaccinated against Covid-19, for example with regard to their freedom of assembly,” said Black and Forsberg. “There is potential for unvaccinated individuals to contract a serious case of coronavirus that we believe would be bad for them but could also negatively affect others, such as if health resources were diverted from non-covidic care Need to become.”

The couple added that if the vaccines are found to be reducing transmission, it might be justified for the state to curb vaccine objectors.

They also stressed that the free circulation of unvaccinated people may be linked to the development and spread of mutations in the virus, some of which may become resistant to vaccines.

Vaccination records

In December, it emerged that Los Angeles County plans to save Covid vaccine recipients a vaccination record in the Apple Wallet on their iPhone, which can also be used to store tickets and boarding passes in digital form. Officials say it will first be used to remind people to get their second shot of the vaccine, but it could eventually be used to gain access to concert venues or airline flights.

“The idea of ​​immunity certificates is not new,” said Kevin Trilli, chief product officer for identity verification startup Onfido, to CNBC. “For example, children who get vaccinated against measles, polio and other diseases often have to show their immunity certificate in order to register at a new school. Health passports could be a way to reopen the economy and the new normal with one Data protection-first approach to manage. ”

Trilli added, “There is a growing appetite for the travel industry to use health passports / certificates to improve the safety of their employees and customers and instill greater levels of trust to catalyze the tourism industry again.”

In May, John Holland-Kaye, CEO of the UK’s busiest airport, Heathrow, backed the introduction of health certification to help the country get out of the then stricter travel restrictions. Heathrow Airport did not immediately respond to CNBC’s request for comment.

Delta Air Lines CEO Ed Bastian said in April that immunity passes could be used to help airmen feel more secure in their personal safety while traveling.

A Ryanair spokesperson said “Vaccinations are not required when flying Ryanair” when CNBC asked if it would ever prevent unvaccinated people from flying its planes. British Airways, Qantas and easyJet did not respond to CNBC’s request for comment.

The situation in Great Britain

Last year, Nadhim Zahawi, the economy minister who was appointed British vaccine tsar in late November, said the public may need an immunity pass to gain access to some locations.

“We’re looking at technology and, of course, a way people can tell their general practitioner (doctor) if they’ve been vaccinated,” Zahawi said on November 30th during an interview with BBC Radio 4. Sports venues are likely to use this system as well. “

Not everyone likes this idea. Sam Berry, who runs two restaurants in South West London called Hideaway and No.97, told CNBC: “We firmly believe that everyone is treated equally. Everyone has a right to their views and beliefs, and we don’t want them to stop. “

He added, “Hospitality would be broken down into restaurants and bars for vaccinated guests and then bars and restaurants for non-vaccinated guests. That sounds just crazy to me.”

Darren Jones, an opposition Labor lawmaker in the UK, told CNBC: “I just hope we have a proper debate and full review of all proposed immunity passports that I assume will be a thing if not a thing are.” “”

Jones added that all immunity passports should be tied to a “long overdue debate about a proper national ID system”.

The vaccine against Oxford-AstraZeneca was approved by UK regulators on December 30th, meaning there are now two safe vaccines available to UK citizens.

But millions of people across the country still don’t want to be vaccinated, according to opinion polls. Some fear needles, others believe in baseless conspiracy theories, and others are concerned about possible side effects. Others just don’t feel it is necessary to get vaccinated and prefer to risk catching Covid.

Cabinet Secretary Michael Gove said December 1 there were “no plans” to introduce a vaccination record, and the Department of Health and Social Welfare echoed the news when contacted by CNBC.

The DHSC said it would be able to collect evidence of the effects on infection rates, hospitalization and reducing deaths as large numbers of people from risk groups receive an effective vaccine.

If successful, it should, over time, lead to a major re-evaluation of the current restrictions.

Categories
Health

A pharmacist accused of sabotaging vaccine doses is a conspiracy theorist, the police say.

A pharmacist accused of sabotaging vaccine doses is a conspiracy theorist, the police say.

A pharmacist arrested for deliberately sabotaging more than 500 doses of the Covid-19 vaccine in a Wisconsin hospital was “a licensed conspiracy theorist” who believed the vaccine could harm people and “alter their DNA”, so the police in Grafton, Wisconsin, where the man was employed.

Police said Steven Brandenburg, 46, who worked the night shift at Aurora Medical Center in Grafton, twice removed a box of Moderna vaccine from the refrigerator for 12 hours, rendering it “unusable.” .

“Brandenburg admitted to having done this on purpose, knowing that it would reduce the effectiveness of the vaccine,” said police.

The attempt to destroy valuable doses of the vaccine came over the holidays as the state worked to quickly deliver vaccines to the health front. As of Saturday, the state had received 159,800 doses of vaccines and administered 64,657, according to the Centers for Disease Control and Prevention. Although the Moderna product is sometimes described as a “genetic” vaccine, it does not alter a person’s genes in any way.

The vials, which held 570 doses of vaccine and were valued at $ 8,000 to $ 12,000 according to prosecutors, were discovered on Dec. 26. Five days later, Mr Brandenburg was arrested for crimes of reckless endangerment and property damage, although prosecutors said Monday the charges could be dropped on a single misdemeanor if the vials, which have yet to be tested, are still usable.

Prosecutor Adam Gerol said Mr. Brandenburg was “quite cooperative and admitted everything he did”. He said that, according to employees, Mr. Brandenburg had already brought a gun to work twice.

In a decision signed on Monday, a family court temporarily granted his wife Gretchen Brandenburg sole custody of the two daughters of Mr Brandenburg and determined that the children were in “immediate danger of physical or mental harm”.

Ms. Brandenburg filed for divorce last June. At a hearing in July, her lawyer testified that his client was afraid of Mr. Brandenburg’s temper.

Categories
Health

India coronavirus vaccine candidate from Cadila Healthcare

India coronavirus vaccine candidate from Cadila Healthcare

SINGAPORE – Indian drug maker Cadila Healthcare is about to start a phase 3 clinical trial for a potential coronavirus vaccine, its chairman told CNBC.

“We are now entering the third phase, which will begin very, very soon,” Pankaj Patel told CNBC’s “Street Signs Asia” on Tuesday.

He said the process will involve around 30,000 volunteers and take around three to three and a half months.

The pharmaceutical company, also known as Zydus Cadila, announced on Sunday that it had received approval from India’s Medicines Agency to begin its Phase 3 clinical trial after previous studies found its DNA vaccine candidate was “safe, well tolerated and immunogenic “.

“We saw that the antibody response was very, very good, in the range of 20 to 80-fold increases in antibodies after the vaccine was given,” said Patel, adding studies that so far indicated that the volunteers the vaccine responded well to it. “We also saw good virus neutralization with it and we didn’t see any side effects to be concerned about.”

“Overall we have very good results and we believe that phase three should actually show us the exact effectiveness of the vaccine,” said Patel. Cadila’s candidate will likely become India’s second domestically developed Covid-19 vaccine when it receives regulatory approval following its phase three study.

Ground staff walk past a container that is being held at Freight Terminal 2 at Indira Gandhi International Airport and will be used as a COVID-19 center for vaccine handling and distribution on December 22, 2020 in New Delhi, India, according to officials becomes.

Anushree Fadnavis | Reuters

Unlike some other Covid-19 vaccines that require extremely cold storage temperatures, Cadila’s candidate can be kept stable at room temperature, according to Patel. That would make it easier to distribute to remote parts of India.

Patel stated that the company already has a distribution system in India and has invested in expanding its manufacturing capacity. He added that the company is also in advanced talks with several other countries to deliver the potential vaccine once it’s ready, but declined to name the nations.

South Asia’s largest country currently has more than 10.35 million reported cases of coronavirus infection, second only to the US. According to the Johns Hopkins University, almost 150,000 people in India are said to have died of Covid-19. However, official figures suggest that the number of cases of active infections is decreasing.

The Indian Medicines Agency on Sunday approved the restricted use of two coronavirus vaccines in emergency situations. One of them is a vaccine developed by AstraZeneca and Oxford University and made locally by the Serum Institute of India. The other was developed by India’s Bharat Biotech in partnership with the Indian State Council for Local Medical Research and received emergency approval if clinical trials continue.

Categories
Health

Operating low on oxygen, emergency employees in Los Angeles County are advised to manage the minimal vital.

Running low on oxygen, emergency workers in Los Angeles County are told to administer the minimum necessary.

California’s daily coronavirus case numbers remain about four times what it was during the state’s summer flood, and officials predict the aftermath of a December wave related to holiday gatherings will worsen over the winter.

After new infections – fueled by Thanksgiving trips and gatherings, then Christmas festivities – led to a surge the state hadn’t seen before, the trend in its new cases flattened somewhat in the early days of 2021.

But there are more than twice as many Covid-19 patients in California hospitals as there were a month ago, and many intensive care units in the state are overcrowded. It has also been found that at least six people in the state are infected with the new, more transmissible variant of the virus first identified in the UK.

The state is also facing a lack of oxygen for patients and has deployed the U.S. Army Corps of Engineers and the California Emergency Medical Services Authority to help with the delivery and refilling of oxygen tanks.

As a sign of how bad the shortage is, Marianne Gausche-Hill, the medical director of the Los Angeles County EMS agency, issued guidelines on Sunday for emergency responders to administer the “minimum amount of oxygen” required keep the patient’s oxygen saturation at a level or just over 90 percent. (Levels in their low 90s or below are an issue for people with Covid-19.)

In the brutal logic of the pandemic, more cases inevitably lead to more suffering and death. As of Monday evening, 4,258 people had died with Covid-19 in the past two weeks, compared to 3,043 in the two weeks prior.

Updated

Jan. 5, 2021, 6:31 p.m. ET

“This is a deadly disease, this is a deadly pandemic,” Governor Gavin Newsom told reporters on Monday. “It remains deadlier today than at any point in the history of the pandemic.”

Some progress has been made. For example, California’s daily average of 38,086 cases per day for the past week is an 11 percent decrease from the average for two weeks earlier. And although hospital stays in Covid-19 have increased 18 percent to 20,618 in the past two weeks, that means a slight flattening of the curve, according to Governor Newsom.

But the state’s last major Covid-19 surge in the summer only caused about 10,000 infections on the worst days. And in Los Angeles County, the recent crisis has made the healthcare system so thin that patients arriving at a hospital were recently ordered to wait in an outdoor tent.

Los Angeles Mayor Eric Garcetti said Sunday that the county’s recent spike infected a new person every six seconds and that many transmissions were in private settings.

“It’s a message for all of America: We may not all have the same density as LA, but what is happening in LA can and will come to many churches in America,” he said.

The state’s worst outbreak is centered in southern California and the San Joaquin Valley, where intensive care units are zero percent. Officials are now working to recruit additional nurses to handle the flood of patients. Governor Newsom said 90 patients were being held in “alternative care locations” outside of hospitals to ease the burden.

More vaccinations would help ease the burden on California, but Governor Newsom said vaccinations were only just increasing after some early challenges. So far, the state has only administered about 35 percent of the coronavirus vaccine doses received.

“That’s not good enough,” he said. “We recognize that.”

In the meantime, says Dr. Mark Ghaly, the secretary of state for health and human services, Californians should be extra careful when meeting with people outside of their household as the virus is so widespread.

“The same activities that you did a month ago today are much riskier today than from a Covid transmission perspective,” he said.

Categories
Health

Israel to enter third nationwide lockdown regardless of profitable Covid vaccination marketing campaign

Israel to enter third national lockdown despite successful Covid vaccination campaign

Despite its early success with the introduction of the Covid-19 vaccine, Israel is quickly facing a third national lockdown amid the spread of the virus.

Prime Minister Benjamin Netanyahu and members of his cabinet blame a faster spread, first seen in the UK last month. Israeli officials confirmed four cases of the strain on December 23, days after British Prime Minister Boris Johnson said it was an emerging problem.

An ultra-Orthodox Jewish man receives a vaccination against coronavirus disease (COVID-19) as Israel continues its national vaccination campaign during a third national COVID lockdown at a Maccabi Healthcare Services office in Ashdod, Israel, on December 29, 2020.

Amir Cohen | Reuters

In a cabinet meeting Tuesday, Netanyahu told ministers, “We are in a state of emergency” as ministers agreed to a lockdown beginning Friday that closes schools, non-essential businesses and forces residents to be within a kilometer of their homes to stop.

It does so amid a global turmoil over a slow adoption of vaccines in the US and elsewhere that Israel largely avoided.

Tom, 69, and Judy Barrett, 67, of Marco Island wait in line early in the morning at the Lakes Park Regional Library to receive the COVID-19 vaccine in Fort Myers, Florida, the United States, on Dec. 30, 2020 . 2020.

Andrew West | USAToday | Reuters

Israeli officials have boasted that the country vaccinated more people in the first nine days of its vaccination campaign than it has had Covid-19 infections since the pandemic began.

The country had already vaccinated around 7% of its 9.2 million inhabitants last week. The Israeli Ministry of Health plans that up to 90% of the “at risk” population will receive their second of two shots from the Pfizer BioNTech vaccine within the next 25 days.

The effectiveness of its vaccination campaign has made it a potential model for the rest of the world, epidemiologists say.

Israel has an early advantage, said Dr. Itamar Grotto, Deputy Director General of the Israeli Ministry of Health and one of those responsible for the prosecution. “We have a national vaccination registry that was set up a few years ago. The whole country is in one database,” he said in an exclusive interview with CNBC.

Registration was started to ensure that children get all of their recordings. This infrastructure enabled Israel to be better prepared for this outbreak than many other countries fighting the virus. Israel had a terrifying dry run for Covid-19 when it was hit by a wild-type poliovirus outbreak in 2013.

The country brought this disease under control with an intensive vaccination campaign that paved the way for today’s vaccine database.

Israel’s medical infrastructure offers several other advantages, he said:

  • Medical care in Israel is largely socialized.
  • Israel only has four health organizations serving citizens across the country while many other nations have more competition in the system.
  • These HMOs are all linked to the country’s national health service, which keeps records of every Israeli citizen.
  • The whole system will be digitized under a single national system.

Before packages containing the Pfizer BioNTech vaccine arrived in Israel on December 9, a government-appointed panel began clarifying who would get the shots in the first wave.

Cardboard boxes containing the Pfizer-BioNTech COVID-19 vaccine are being prepared for shipment at the Pfizer Global Supply Kalamazoo manufacturing facility in Portage, Michigan on December 13, 2020.

Morry Gash | Pool | Reuters

At the same time, the Ministry of Health began setting up a communication and distribution system so that the vials of the vaccine could arrive immediately, he said.

Patients in the database of the first group who received the vaccine were given an appointment via email, text, or an online registration form with a date and time period to receive their shot. Regular clinics, community centers, hospitals and some sports stadiums have been converted into vaccination centers and staffed with previously trained health care workers awaiting action, he said.

Because the vaccine cannot be frozen after thawing, Israel is encouraging vaccination site managers to use any dose.

According to Grotto, there is a ready list of people who can intervene at short notice if other people fail to show up at the end of the day. Officials at distribution centers also divide the vials into smaller packages suitable for each center. This is another attempt at avoiding waste.

However, the challenges facing Israel are far from over. Health officials recently confirmed that nearly 500 doses were wasted in the south of the country because health workers failed to get enough people ready to come to vaccination centers.

Israel expects more deliveries from Pfizer. Business has also been made with Moderna and AstraZeneca, but these recordings have not yet been delivered. But they are expected soon. Israel is also working on its own vaccine, but there is no word on when it will be ready.

Categories
Health

A New Software in Treating Psychological Sickness: Constructing Design

A New Tool in Treating Mental Illness: Building Design

Residents of the Pigeon Pavilion in Mountain View, California wake up in private rooms with views of the forested Santa Cruz Mountains, have breakfast in airy communal spaces, and relax in landscaped courtyards throughout the day.

It may sound like a resort, but the Pigeon Pavilion is a $ 98 million mental health facility that opened in June as part of El Camino Hospital. The 56,000-square-foot building was designed by WRNS Studio and is part of a new wave of facilities that dwarfs outdated institutional models.

Mental hospitals have been a grim environment for decades, with patients being pushed into common rooms during the day and dormitories at night. However, new research into the health effects of our surroundings is driving the development of facilities that feel more homely, with inviting entrances, smaller units in larger buildings, and a variety of meeting rooms. Nature plays a major role: windows offer a view of the greenery, landscapes adorn walls and outdoor areas offer patients and staff access to fresh air and sunlight.

The new approach promoted as healing and therapeutic has resulted in environments that are more calming and supportive. And it feels especially timely, given the rise in mental health problems caused by the pandemic.

“We’ve been talking about it for a long time,” said Mardelle McCuskey Shepley, chair of the design and environmental analysis department at Cornell’s College of Human Ecology. “Only now is it gaining momentum.”

Even before the pandemic, the number of Americans affected by mental illness was at a new high. One in five adults had depression, bipolar disorder, schizophrenia, post-traumatic stress, or another illness, according to the National Institute of Mental Health. The rates were significantly higher in adolescents (approx. 50 percent) and young adults (approx. 30 percent).

Almost a year after the pandemic started, more people are suffering. Young adults and blacks and Latinos of all ages report increased levels of anxiety, depression and substance abuse, according to a survey by the Centers for Disease Control and Prevention. A recent Gallup poll found Americans felt their mental health was “worse than it has ever been in the past two decades.”

The demand for treatments has increased, and the construction of mental health facilities has surpassed the construction of other specialty hospitals. Last year, 40 percent of specialty hospitals under construction were psychiatric hospitals and behavioral health centers, according to the American Society for Health Care Engineering.

Architecture and interior design firms with expertise in healthcare buildings have reported an increase in activity. Architecture + design firm in Troy, NY typically has a major mental health facility or two in the pipeline. The total construction cost for these projects is approximately $ 250 million per year, said Francis Murdock Pitts, principal and founding partner. Over the past year, the company worked on 16 major mental health projects totaling approximately $ 1.9 billion.

His company and others who like it have medical planners on staff to help translate research into “evidence-based” designs. “This is not all about being warm and hazy,” said Pitts.

For example, exposure to nature has been shown to lower cortisol levels, a measure of stress. Adding medicinal gardens and other greenery can help calm agitated patients and give staff a place to decompress.

Research specifically related to mental health care also comes into play. Studies have shown that reducing the crowd by providing private rooms and multiple common areas can reduce stress and aggression from patients and staff. Noise reduction – for example, the unnecessary beeping of medical equipment – can also help. When patients are less stressed, they can make faster, more sustained progress during treatment, experts say.

Economy & Economy

Updated

Jan. 5, 2021, 11:06 p.m. ET

However, because mental health issues vary widely, there is no one-size-fits-all design solution. And safety – for both patients and staff – continues to come first.

Codes and guidelines refined over many years have sought to remove spatial features that patients have used to harm themselves and others. Window glazing is made from polycarbonate compounds to reduce breakage. The doors are hung on quick release hinges so that staff can enter a room if a patient is barricaded. Plumbing and other fixtures are designed to prevent the possibility of hanging or strangling.

Such security measures are vital, but “You don’t want them to get to where they look like a prison,” said Shary Adams, principal at HGA, a national design firm. While the built environment must be designed to ensure safety, there is also a measure to give patients some control over their surroundings. With manual thermostats, for example, patients can set the temperature in their rooms, and with dimmer switches they can modulate the light.

The location of the psychiatric facilities is also changing. Psychiatric facilities used to be hidden, now they are likely part of hospital grounds or otherwise conveniently located. They often combine inpatient rooms for those in need of 24/7 surveillance and areas for outpatient services so patients can move to less intensive care in the same building.

A state-of-the-art center for young people in Monterey, California illustrates the new approach. Montage Health, a non-profit provider, laid the foundation stone for the 55,600 square meter building in November.

Called Ohana, a Hawaiian word for an expanded family concept, the facility will provide young patients with psychiatric treatment, sometimes involving their parents and siblings. Early care is crucial with half of all lifelong mental illnesses showing up by age 15 and 75 percent by age 24, said Dr. Susan Swick, Ohana Senior Medical Officer.

She asked NBBJ architects to come up with a design that contained the wonder of a children’s museum or public library – “a place you walk makes you feel like you have the opportunity”.

The building will wrap itself around beautiful old oak trees on the hillside overlooking a green valley. It will house inpatient rooms, an outpatient treatment wing, several classrooms and a large number of rooms for group and individual therapies.

The grounds offer areas for yoga and informal gatherings. The paths are lined with cedar and pine, rosemary and lavender – plants whose scents activate “natural killer cells” that can boost immunity, said Richard Dallam, managing partner at NBBJ and head of health practice for the company.

“It’s not just pretty; it’s functional, ”he added.

With its swoops and turns, Ohana looks like a complicated building to construct, but it is constructed from cross-laminated timber in modules that can be assembled off-site, reducing costs and speeding up construction. Its price tag: $ 50 million, which is covered by a $ 106 million donation that also provides funding for clinical services.

Still, not every hospital system has an angel investor, and buildings with these new designs are more expensive to build – private rooms alone add to the cost.

Proponents say, however, that upfront spending can lead to savings later and improve employee retention, for example because employees are less prone to burnout and need to be replaced with new employees who need training.

“We try to use evidence-based design to help clients connect to other things on their balance sheet,” said Angela Mazzi, director at GBBN and president of the American College of Healthcare Architects, a certification organization. “If you invest in some of these things that aren’t directly part of the clinical field, you get different results and a different kind of payback.”

Categories
Health

The UK is delaying second Pfizer/BioNTech shot: Here is what we all know

The UK is delaying second Pfizer/BioNTech shot: Here's what we know

The medical staff will receive the Pfizer-Biontech Covid-19 coronavirus vaccine in the Favoriten Clinic in Vienna on December 27, 2020 on the occasion of the launch of the Pfizer-BioNTech Covid-19 coronavirus vaccine.

Georg Hochmuth | AFP | Getty Images

The UK’s decision to delay the administration of the second dose of a coronavirus vaccine is controversial as experts, advisors and vaccine manufacturers weigh the strategy.

The UK was one of the first countries in the world to launch a mass vaccination campaign against the coronavirus after approving the Covid-19 vaccine developed by Pfizer and BioNTech in early December. Oxford University and AstraZeneca began rolling out the vaccine on Monday of this week after it was approved for use just before the New Year.

As both vaccines require two doses per person, the UK government initially said that a second dose would be given either three or four weeks after the first dose, depending on which vaccine was given and in line with the dosage regimens tested in clinical trials.

However, a break of up to 12 weeks is now recommended to give more people an initial dose – and initial protection against Covid-19.

Concerns from the vaccine manufacturer

BioNTech and Pfizer have responded to the decision, saying there is no evidence that their vaccine will continue to protect against Covid-19 if the second shot is given more than 21 days after the starting dose.

“Pfizer and BioNTech’s Phase 3 study of the COVID-19 vaccine was designed to evaluate the safety and efficacy of the vaccine on a 2-dose regimen separated by 21 days. The safety and efficacy The majority of study participants received the second dose within the window specified in the study design, “the companies said in a statement to CNBC on Tuesday.

“Although data from the Phase 3 study showed partial protection from the vaccine as early as 12 days after the first dose, there is no data to show that protection is maintained after 21 days after the first dose.”

The companies said it was now “critical to conduct surveillance efforts” with alternative dosing schedules in place.

The final analysis of data from the Pfizer / BioNTech clinical trials found the vaccine to be 95% effective given seven days after the second dose in preventing Covid-19.

For the Oxford University / AstraZeneca candidate, the interim analysis of the late-stage study results was somewhat more nuanced, as the vaccine doses to the study participants showed an anomaly. When the vaccine was given in two full doses, it was found to be 62.1% effective, but when some study participants received half a dose followed by a full dose of 90%. In both dosing regimens, the two shots were given one month apart. AstraZeneca was not immediately available for comment on the UK’s decision to postpone the second dose.

Reasons for the decision

The decision to extend the dosage window is made as UK hospitals struggle with increasing admissions. The coronavirus is running amok in the UK, with a new, transmissible strain of the virus spreading exponentially in London and the South East, and now appearing in other parts of the country.

To date, the country has recorded over 2.6 million cases of coronavirus and more than 75,000 deaths, according to Johns Hopkins University. The UK recorded 58,784 new cases on Monday and has now reported more than 50,000 new coronavirus cases for seven days in a row. On Monday, British Prime Minister Boris Johnson announced a third nationwide lockdown for England.

Against this dire backdrop, the UK Medicines Agency, Joint Vaccination and Immunization Committee and the UK’s four chief medical officers agreed to move the gap between the first and second vaccine dose to “protect the greatest number of people in India” the shortest Time. “

There are signs that other Britain may follow suit. The German Ministry of Health is now asking an independent vaccination commission for advice on whether the British strategy on dose delay should be adhered to. Denmark has reportedly already approved a delay of up to six weeks between the first and second vaccinations.

‘Finely balanced’

So far, more than a million people in the UK have been vaccinated with the Pfizer / BioNTech vaccine, according to government figures, and some, like the first recipient of this vaccine outside of a clinical trial, have received their second dose.

But now, thousands of others in the top priority category are being told to wait up to 12 weeks for their second dose.

The British Medical Association described the move as “grossly unfair” to thousands of high-risk patients in England, but the UK’s Independent Scientific Advisory Group on Emergencies (SAGE) said in a statement released on Sunday that it was a “very difficult and finely balanced” move be decision. “

In response to the BMA’s concerns, SAGE said, “Under normal circumstances, we would advocate continuing our previous plans to give two doses of the Pfizer BioNTech vaccine 21 days apart. However, these are not normal circumstances, and so it is are other important public health considerations. “

The UK is prioritizing vaccination of elderly care home residents, their carers, people over 80, and frontline health and social workers.

The country has pre-ordered 40 million doses of the Pfizer / BioNTech vaccine, enough for 20 million people, and signed a contract with AstraZeneca for 100 million doses, enough for 50 million people. There are around 66 million people in Great Britain.